Literature DB >> 25553516

Replication-competent influenza A viruses expressing a red fluorescent protein.

Aitor Nogales1, Steven F Baker1, Luis Martínez-Sobrido2.   

Abstract

Like most animal viruses, studying influenza A in model systems requires secondary methodologies to identify infected cells. To circumvent this requirement, we describe the generation of replication-competent influenza A red fluorescent viruses. These influenza A viruses encode mCherry fused to the viral non-structural 1 (NS1) protein and display comparable growth kinetics to wild-type viruses in vitro. Infection of cells with influenza A mCherry viruses was neutralized with monoclonal antibodies and inhibited with antivirals to levels similar to wild-type virus. Influenza A mCherry viruses were also able to lethally infect mice, and strikingly, dose- and time-dependent kinetics of viral replication were monitored in whole excised mouse lungs using an in vivo imaging system (IVIS). By eliminating the need for secondary labeling of infected cells, influenza A mCherry viruses provide an ideal tool in the ongoing struggle to better characterize the virus and identify new therapeutics against influenza A viral infections.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  2A; Antivirals; In vivo imaging system (IVIS); Influenza A virus; Interferon; Microneutralization assay; NS1; Neutralizing antibodies; Replication-competent virus; Virus neutralization assay; mCherry

Mesh:

Substances:

Year:  2014        PMID: 25553516      PMCID: PMC4323957          DOI: 10.1016/j.virol.2014.12.006

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  65 in total

1.  "Ambisense" approach for the generation of influenza A virus: vRNA and mRNA synthesis from one template.

Authors:  E Hoffmann; G Neumann; G Hobom; R G Webster; Y Kawaoka
Journal:  Virology       Date:  2000-02-15       Impact factor: 3.616

2.  Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children.

Authors:  João Toniolo Neto
Journal:  Sao Paulo Med J       Date:  2014       Impact factor: 1.044

3.  Influenza A virus NEP (NS2 protein) downregulates RNA synthesis of model template RNAs.

Authors:  R Bullido; P Gómez-Puertas; M J Saiz; A Portela
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

4.  Influenza virus assembly: effect of influenza virus glycoproteins on the membrane association of M1 protein.

Authors:  A Ali; R T Avalos; E Ponimaskin; D P Nayak
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

Review 5.  Plasmid-only rescue of influenza A virus vaccine candidates.

Authors:  J H Schickli; A Flandorfer; T Nakaya; L Martinez-Sobrido; A García-Sastre; P Palese
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-12-29       Impact factor: 6.237

6.  Cellular transcriptional profiling in influenza A virus-infected lung epithelial cells: the role of the nonstructural NS1 protein in the evasion of the host innate defense and its potential contribution to pandemic influenza.

Authors:  Gary K Geiss; Mirella Salvatore; Terrence M Tumpey; Victoria S Carter; Xiuyan Wang; Christopher F Basler; Jeffery K Taubenberger; Roger E Bumgarner; Peter Palese; Michael G Katze; Adolfo García-Sastre
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-29       Impact factor: 11.205

7.  Inhibition of arenavirus by A3, a pyrimidine biosynthesis inhibitor.

Authors:  Emilio Ortiz-Riaño; Nhi Ngo; Stefanie Devito; Dirk Eggink; Joshua Munger; Megan L Shaw; Juan Carlos de la Torre; Luis Martínez-Sobrido
Journal:  J Virol       Date:  2013-11-06       Impact factor: 5.103

Review 8.  New-generation screening assays for the detection of anti-influenza compounds targeting viral and host functions.

Authors:  Grant Beyleveld; Kris M White; Juan Ayllon; Megan L Shaw
Journal:  Antiviral Res       Date:  2013-08-06       Impact factor: 5.970

9.  Crystallographic fragment screening and structure-based optimization yields a new class of influenza endonuclease inhibitors.

Authors:  Joseph D Bauman; Disha Patel; Steven F Baker; R S K Vijayan; Amy Xiang; Ajit K Parhi; Luis Martínez-Sobrido; Edmond J LaVoie; Kalyan Das; Eddy Arnold
Journal:  ACS Chem Biol       Date:  2013-09-13       Impact factor: 5.100

10.  Influenza a virus assembly intermediates fuse in the cytoplasm.

Authors:  Seema S Lakdawala; Yicong Wu; Peter Wawrzusin; Juraj Kabat; Andrew J Broadbent; Elaine W Lamirande; Ervin Fodor; Nihal Altan-Bonnet; Hari Shroff; Kanta Subbarao
Journal:  PLoS Pathog       Date:  2014-03-06       Impact factor: 6.823

View more
  45 in total

1.  Interplay of PA-X and NS1 Proteins in Replication and Pathogenesis of a Temperature-Sensitive 2009 Pandemic H1N1 Influenza A Virus.

Authors:  Aitor Nogales; Laura Rodriguez; Marta L DeDiego; David J Topham; Luis Martínez-Sobrido
Journal:  J Virol       Date:  2017-08-10       Impact factor: 5.103

2.  Competitive detection of influenza neutralizing antibodies using a novel bivalent fluorescence-based microneutralization assay (BiFMA).

Authors:  Steven F Baker; Aitor Nogales; Felix W Santiago; David J Topham; Luis Martínez-Sobrido
Journal:  Vaccine       Date:  2015-06-01       Impact factor: 3.641

3.  Temperature-Sensitive Live-Attenuated Canine Influenza Virus H3N8 Vaccine.

Authors:  Aitor Nogales; Laura Rodriguez; Caroline Chauché; Kai Huang; Emma C Reilly; David J Topham; Pablo R Murcia; Colin R Parrish; Luis Martínez-Sobrido
Journal:  J Virol       Date:  2017-01-31       Impact factor: 5.103

4.  Functional Evolution of the 2009 Pandemic H1N1 Influenza Virus NS1 and PA in Humans.

Authors:  Aitor Nogales; Marta L DeDiego; Luis Martinez-Sobrido; Kevin Chiem; David J Topham
Journal:  J Virol       Date:  2018-09-12       Impact factor: 5.103

5.  Cigarette smoke dampens antiviral signaling in small airway epithelial cells by disrupting TLR3 cleavage.

Authors:  Parker F Duffney; Claire E McCarthy; Aitor Nogales; Thomas H Thatcher; Luis Martinez-Sobrido; Richard P Phipps; Patricia J Sime
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-12-14       Impact factor: 5.464

6.  Influenza A Virus Studies in a Mouse Model of Infection.

Authors:  Laura Rodriguez; Aitor Nogales; Luis Martínez-Sobrido
Journal:  J Vis Exp       Date:  2017-09-07       Impact factor: 1.355

7.  Aryl and Arylalkyl Substituted 3-Hydroxypyridin-2(1H)-ones: Synthesis and Evaluation as Inhibitors of Influenza A Endonuclease.

Authors:  Hye Yeon Sagong; Joseph D Bauman; Aitor Nogales; Luis Martínez-Sobrido; Eddy Arnold; Edmond J LaVoie
Journal:  ChemMedChem       Date:  2019-05-14       Impact factor: 3.466

Review 8.  Development and applications of single-cycle infectious influenza A virus (sciIAV).

Authors:  Aitor Nogales; Steven F Baker; William Domm; Luis Martínez-Sobrido
Journal:  Virus Res       Date:  2015-07-26       Impact factor: 3.303

9.  Rearrangement of Influenza Virus Spliced Segments for the Development of Live-Attenuated Vaccines.

Authors:  Aitor Nogales; Marta L DeDiego; David J Topham; Luis Martínez-Sobrido
Journal:  J Virol       Date:  2016-06-24       Impact factor: 5.103

10.  PRESCIENT: platform for the rapid evaluation of antibody success using integrated microfluidics enabled technology.

Authors:  Jose A Wippold; Han Wang; Joseph Tingling; Julian L Leibowitz; Paul de Figueiredo; Arum Han
Journal:  Lab Chip       Date:  2020-03-20       Impact factor: 6.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.